Professor, Medicine, University of Connecticut SOM
Oncology
Dr. Jonathan R. Sporn, MD
|
|
Give Review
Dr. Jonathan R. Sporn is an expert in the field of Oncology. He studied medicine at State University of New York Upstate Medical University. Jonathan R. Sporn, MD is also a published physician. He has 31 publication published. The most recent publication is: Practical recommendations for the management of adenocarcinoma of the pancreas. Jonathan R. Sporn accepts Medicare payments and is registered with Medicare.gov.
Publications
- A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury.
- Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial.
- An open-label trial of riluzole in patients with treatment-resistant major depression.
- Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation.
- Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
- Monoamine and neuropeptide-related function: prospects for novel therapeutics of depression.
- Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
- Reversible granulocytopenia in association with riluzole therapy.
- Unusual presentation of a Merkel cell carcinoma.
- Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based ...
- Practical recommendations for the management of adenocarcinoma of the pancreas.
- Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma.
- The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness.
- Treatment of advanced pancreatic adenocarcinoma with 5-FU, leucovorin, interferon-alpha-2b, and cisplatin.
- Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vacc...
- Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells.
- The role of flow cytometry in the diagnosis of lymphoma: a critical analysis.
- Adoptive immunotherapy with peripheral blood lymphocytes cocultured in vitro with autologous tumor cells and interleukin-2.
- Empirical chemotherapy for adenocarcinoma of unknown primary tumor site.
- Immunological techniques to differentiate lymphoma from other malignancies.
- Acute adult T-cell leukemia/lymphoma presenting with florid cutaneous disease.
- Recovery from widespread bone marrow necrosis occurring after chemotherapy for adult acute monocytic leukemia.
- Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytes.
- Sustained response of refractory prolymphocytic leukemia to fludarabine.
- Platinum in blood mononuclear cells from patients after cisplatin therapy.
- Empiric chemotherapy in patients with carcinoma of unknown primary site.
- Attitudes and practices regarding adjuvant chemotherapy in node-negative breast cancer.
- Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry.
- Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
- Pregabalin for the treatment of postoperative pain: results from three controlled trials using different surgical models.
Schools
SUNY Upstate Medical University Syracuse
University Mass Med Center
Dartmouth Hitchcock Med Center
Yale University
Procedures Preformed
- Biological Therapy
- Blood Test
- Cancer Counseling
- Cancer Treatment
- View All
Doctors Specialties
- Breast Oncology
- Gastrointestinal Oncology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Dartmouth-Hitchcock Medical Center -
University of Massachusetts -
State University of New York Upstate Medical University
Drug Facts
| NPI NUMBER | 1700889771 | |
| NPPES Provider LastName | SPORN | |
| NPPES Provider FirstName | JONATHAN | |
| NPPES Provider ZIPCode | 061051217 | |
| NPPES Provider State | CT | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 479.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 33.0 | |
| Percent Opioid Claims | 6.89 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700889771 |
| Last Name Of The Provider | SPORN |
| First Name Of The Provider | JONATHAN |
| View All |
Similar Doctors
|
Dr. Patricia Defusco, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Zia U. Rahman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madhavi Gorusu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohanakrishin Menon, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James J. Vredenburgh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Adam Boruchov, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alessia C. Donadio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd J. Alekshun, MD
This Doctor is OpenDoctor Recommended.
|